AWA
NVAX icon

Arkadios Wealth Advisors’s Novavax NVAX Stock Holding History

Arkadios Wealth Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-47,630
Closed -$3.51M – 585
2022
Q1 		$3.51M Buy
47,630
+46,089
+2,991% +$4.11M 0.46% 49
2021
Q4 		$220K Sell
1,541
-110
-7% -$18.9K 0.03% 525
2021
Q3 		$342K Buy
1,651
+946
+134% +$208K 0.05% 372
2021
Q2 		$149K Sell
705
-1,770
-72% -$324K 0.02% 614
2021
Q1 		$448K Buy
2,475
+1,875
+313% +$374K 0.07% 265
2020
Q4 		$66K Buy
600
+100
+20% +$10.6K 0.01% 503
2020
Q3 		$53.5K Hold
500
– – 0.03% 396
2020
Q2 		$55K Sell
500
-500
-50% -$19.1K 0.03% 359
2020
Q1 		$13.6K Buy
+1,000
New +$8.46K 0.01% 564

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Arkadios Wealth Advisors's NVAX Position: Q2 2022 in Review

Arkadios Wealth Advisors sold out of Novavax (NVAX) in Q2 2022, closing a stake of 47,630 shares — an estimated $3.51M sold.

Arkadios Wealth Advisors first reported a position in NVAX in Q1 2020 and held it in 9 quarters. The position peaked at $3.51M in Q1 2022. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • Arkadios Wealth Advisors reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • Arkadios Wealth Advisors sold 47,630 Novavax shares in Q2 2022, an estimated $3.51M.
  • Arkadios Wealth Advisors first reported a position in Novavax in Q1 2020 and held it in 9 quarters.
  • Arkadios Wealth Advisors's Novavax position peaked at $3.51M in Q1 2022.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Arkadios Wealth Advisors's 13F filing for Q2 2022, filed 14 Jul 2022.